Advertisement
Advertisement
September 12, 2022
Optimed’s Tentos 4-F Stent System Launched in Europe and Other CE Mark Countries
September 12, 2022—Optimed, which is based in Ettlingen, Germany, announced the launch of the Tentos 4-F self-expanding stent system for the treatment of superficial femoral and infrapopliteal arteries. It is now commercially available in more than 70 countries that recognize CE Mark.
According to the company, the Tentos stent is offered in diameters of 3 to 8 mm and is compatible with 0.018-inch guidewires. The delivery system features a low crossing profile and is compatible with all 4-F sheaths.
The Tentos stent is designed with thinner struts and shorter stent rings and provides tighter stent wall apposition compared to conventional superficial femoral artery stents. The Tentos system also has enhanced vessel coverage, conformability, and visibility compared to Optimed’s current 4-F stent system, stated the company.
Advertisement
Advertisement
